Blackstone exec: Costly new weight-loss drugs could bankrupt employers

Blackstone exec warned costly new weight-loss drugs like GLP-1s could bankrupt some employers due to 600% cost spike.

Panelists debated whether employers should cover the drugs, considering the high costs.

One view Don't let costs restrict access; obesity drugs give people their lives back.

Another view Employers should only cover along with lifestyle support programs.

Panelists agreed covering drugs alone without support is "waste of money."